NexGel Inc (NXGL)
2.51
+0.03
(+1.21%)
USD |
NASDAQ |
Oct 04, 16:00
2.60
+0.09
(+3.59%)
After-Hours: 20:00
NexGel Research and Development Expense (Annual): 0.103M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.103M |
| December 31, 2022 | 0.367M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.031M |
| December 31, 2020 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
2020
0.367M
Maximum
2022
0.1253M
Average
0.067M
Median
Research and Development Expense (Annual) Benchmarks
| The Cooper Companies Inc | 137.40M |
| Staar Surgical Co | 44.40M |
| OrthoPediatrics Corp | 10.20M |
| Innovative Eyewear Inc | 0.6622M |
| Perspective Therapeutics Inc | 21.31M |